This meeting will cover the latest on the genetic etiology of metabolic dysfunction-associated steatohepatitis (MASH), metabolic and inflammatory drivers of the disease, preclinical modeling of the disease, non-invasive markers for diagnosis, and existing and emerging therapeutics. The meeting will be held jointly with the Keystone Symposium on Obesity and Adipose Tissue to encourage cross-disciplinary insights and collaborations toward understanding underlying mechanisms of how obesity leads
This is a synergistic pairing, given that lipodystrophy has long been known to promote severe MAFLD and ways to reduce overall obesity are also being tried for MAFLD, such as with bariatric surgery and now GLP-1 and dual GLP-1/GIP agonists. Joint sessions on human genetics and therapeutics across MASH and obesity will facilitate interaction between endocrinologists, hepatologists, adipose and liver biologists for synergy
1.
When Should Immunocompromised Individuals Receive a COVID Booster?
2.
Home Screening Appeals to Women Facing Healthcare Barriers
3.
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer
4.
Prolonged Screen Time Linked to Sleep Issues in Preschoolers
5.
Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
3.
Artificial Intelligence for Bone Marrow Cellular Ecosystem Modeling
4.
Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes
5.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part XIII
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
5.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
Recommended News For You
1.
'Converging' Evidence of Link Between Air Pollution and Breast Cancer
2.
A single bout of exercise gives results that could help cancer patients
3.
Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.
4.
Belzutifan Combo Could be Second-Line Option in Advanced RCC
5.
Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study
Conferences That Might Interest You
Recommended Articles For You
1.
Understanding Protein C Deficiency: Symptoms, Causes, and Treatment
2.
Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions
3.
Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients
4.
Emerging Frameworks in Oncology in Clinical Decision-Making
5.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation